BridgeBio Pharma (BBIO) Interest Coverage Ratio (2018 - 2026)
BridgeBio Pharma (BBIO) reported Interest Coverage Ratio of 5.22 for Q1 2026, down 16.28% on a YoY basis from 6.23 in Q1 2025, and up 56.52% sequentially from 11.99 in Q4 2025.
BridgeBio Pharma (BBIO) Interest Coverage Ratio (2018 - 2026) Analysis & Trends
BridgeBio Pharma (BBIO) has 9 years of Interest Coverage Ratio data on file, last reported at 5.22 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 16.28% year-over-year to 5.22; the trailing twelve-month figure through Mar 2026 stood at 6.81 (down 1.04% YoY), and the FY2025 full-year result was 0.54, up 33.68% from the prior year.
- Interest Coverage Ratio advanced to 5.22 in Q1 2026, from 11.99 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.01 in Q1 2024 to a low of 11.99 in Q4 2025.
- A 5-year average of 5.61 and a median of 5.72 in 2023 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio jumped 100.17% in 2024 and slumped 46277.89% in 2025, its largest moves.
- Tracing BBIO's Interest Coverage Ratio over 5 years: stood at 3.93 in 2022, then slumped by 48.1% to 5.82 in 2023, then plunged by 77.43% to 10.33 in 2024, then dropped by 16.07% to 11.99 in 2025, then soared by 56.52% to 5.22 in 2026.
- Business Quant data shows BBIO's Interest Coverage Ratio at 5.22 in Q1 2026, 11.99 in Q4 2025, and 2.34 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn | -5.22 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.22 |
| Dec 31, 2025 | -11.99 |
| Sep 30, 2025 | -2.34 |
| Jun 30, 2025 | -0.65 |
| Mar 31, 2025 | -4.49 |
| Dec 31, 2024 | -10.33 |
| Sep 30, 2024 | -8.31 |
| Jun 30, 2024 | -2.66 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | -5.82 |
| Sep 30, 2023 | -7.77 |
| Jun 30, 2023 | -7.09 |
| Mar 31, 2023 | -5.72 |
| Dec 31, 2022 | -3.93 |
| Sep 30, 2022 | -6.51 |
| Jun 30, 2022 | -3.95 |
| Mar 31, 2022 | -8.54 |
| Dec 31, 2021 | -7.31 |
| Sep 30, 2021 | -5.91 |
| Jun 30, 2021 | -0.89 |